Golimumab: In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

ISSN： 1173-8804

Source： BioDrugs, Vol.23, Iss.2, 2009-06, pp. : 125-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis

By Tobin Anne-Marie Kirby Brian

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 47-57

Adis International

Access to resources Recommend Favorite

Psoriatic Arthritis: Recognition and Management

By Bruce I.N. Gladman D.D.

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Targeting Tumour Necrosis Factor in the Treatment of Rheumatoid Arthritis

By Pearce G.J. Chikanza I.C.

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 139-149

Adis International

Access to resources Recommend Favorite

Ankylosing Spondylitis: Current Approaches to Treatment

By Toivanen A. Möttönen T.

BioDrugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 193-200

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in Drugs 2002; 62 (17): 2493-2537.

By Culy C.R. Keating G.M.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite